Skip to search.
 TSX Up 0.71% TSX Ventures Up 1.85%

Cytori Therapeutics, Inc. (CYTX)

-NasdaqGM
0.32 Aug 28, 4:00PM EDT
|Pre-Market : 0.34 Up 0.02 (6.38%) 9:04AM EDT
Add to Portfolio
Prev Close:0.32
Open:N/A
Bid:0.34 x 500
Ask:0.38 x 100
1y Target Est:4.00
Beta:4.9841
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:0.28 - 1.47
Volume:2,100
Avg Vol (3m):1,706,110
Market Cap:52.28M
P/E (ttm):N/A
EPS (ttm):-0.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
CYTX 0.00%52.28M
OSIR645.05M
ASTMN/A
BAX21.14B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.45
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.23
Quarterly EPS Est (Sep-15) :-0.06
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Cytori Therapeutics, Inc., a biotechnology company, develops cell therapeutics for specific diseases and medical conditions. The company primarily provides Cytori Cell Therapy consisting of a heterogeneous population of specialized cells, includin... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback